| Effects of message framing on patients’ perceptions and willingness to change to a biosimilar in a hypothetical drug switch C Gasteiger, ASK Jones, M Kleinstäuber, M Lobo, R Horne, N Dalbeth, ... Arthritis Care & Research 72 (9), 1323-1330, 2020 | 46 | 2020 |
| Patients’ beliefs and behaviours are associated with perceptions of safety and concerns in a hypothetical biosimilar switch C Gasteiger, M Lobo, N Dalbeth, KJ Petrie Rheumatology international 41 (1), 163-171, 2021 | 28 | 2021 |
| Robot-delivered cognitive stimulation games for older adults: Usability and acceptability evaluation N Gasteiger, HS Ahn, C Gasteiger, C Lee, J Lim, C Fok, BA Macdonald, ... ACM Transactions on Human-Robot Interaction (THRI) 10 (4), 1-18, 2021 | 21 | 2021 |
| The more the merrier! Barriers and facilitators to the general public’s use of a COVID-19 contact tracing app in New Zealand N Gasteiger, C Gasteiger, K Vedhara, E Broadbent Informatics for Health and Social Care 47 (2), 132-143, 2022 | 17 | 2022 |
| Predictors of parental stress from admission to discharge in the neonatal special care unit JL Hames, C Gasteiger, MR McKenzie, S Rowley, AS Serlachius, V Juth, ... Child: Care, Health and Development 47 (2), 243-251, 2021 | 16 | 2021 |
| Predicting patient reassurance after colonoscopy: the role of illness beliefs C Gasteiger, R Sherriff, A Fraser, MC Shedden-Mora, KJ Petrie, ... Journal of psychosomatic research 114, 58-61, 2018 | 10 | 2018 |
| The mode of delivery and content of communication strategies used in mandatory and non-mandatory biosimilar transitions: a systematic review with meta-analysis C Gasteiger, AA Den Broeder, S Stewart, N Gasteiger, U Scholz, ... Health psychology review 17 (1), 148-168, 2023 | 9 | 2023 |
| A bio-what? Medical companions’ perceptions towards biosimilars and information needs in rheumatology C Gasteiger, U Scholz, KJ Petrie, N Dalbeth Rheumatology international 42 (11), 1993-2002, 2022 | 9 | 2022 |
| Moving forward: Implementing health psychology research to improve patient acceptance of biosimilars C Gasteiger, KJ Petrie Research in Social and Administrative Pharmacy 18 (10), 3860-3863, 2022 | 9 | 2022 |
| Is three a crowd? The influence of companions on a patient’s decision to transition to a biosimilar C Gasteiger, KM Groom, M Lobo, U Scholz, N Dalbeth, KJ Petrie Annals of Behavioral Medicine 56 (5), 512-522, 2022 | 7 | 2022 |
| Clients' experiences of online therapy in the early stages of a COVID‐19 world: A scoping review K van Kessel, S de Pont, C Gasteiger, S Goedeke Counselling and Psychotherapy Research 24 (1), 27-38, 2024 | 4 | 2024 |
| Pharmacists' confidence in explaining biosimilars to patients before a nationwide medicine change: A cross-sectional study C Gasteiger, N Gasteiger, KJ Petrie Exploratory Research in Clinical and Social Pharmacy 8, 100199, 2022 | 3 | 2022 |
| Characteristics associated with the willingness to receive a COVID-19 vaccine and an exploration of the general public's perceptions: A mixed-methods approach N Gasteiger, C Gasteiger, K Vedhara, E Broadbent Vaccine 40 (25), 3461-3465, 2022 | 3 | 2022 |
| Using family-centered communication to optimize patient-provider-companion encounters about changing to biosimilars: A randomized controlled trial C Gasteiger, A Perera, R Yielder, U Scholz, N Dalbeth, KJ Petrie Patient education and counseling 106, 142-150, 2023 | 2 | 2023 |
| Community-based support to improve mental health and wellbeing in older sexually and gender diverse people: A scoping review C Gasteiger, P Collens, E du Preez Aging & Mental Health 28 (4), 692-700, 2024 | 1 | 2024 |
| Health Care Providers’ Experiences of a Mandatory Nationwide Transition to an Adalimumab Biosimilar C Gasteiger, M Lobo, LS Wong, R Murdoch, N Dalbeth ACR Open Rheumatology 5 (12), 644-651, 2023 | 1 | 2023 |
| Rheumatology Patients’ Experiences of a Mandatory Nationwide Transition to an Adalimumab Biosimilar C Gasteiger, M Lobo, R Stanley, LS Wong, R Murdoch, N Dalbeth ACR Open Rheumatology 6 (2), 64-71, 2024 | | 2024 |
| Rheumatology Patients′ Experiences of a Nationwide Transition to an Adalimumab Biosimilar: A Cross-Sectional Study C Gasteiger, M Lobo, R Stanley, LS Wong, R Murdoch, N Dalbeth ARTHRITIS & RHEUMATOLOGY 75, 665-666, 2023 | | 2023 |
| 8.03 Symptom Perception and Interpretation C Gasteiger, KJ Petrie Comprehensive Clinical Psychology, 2022 | | 2022 |
| Improving the Transition to Biosimilars: The Influence of Communication Strategies, Companions and Patient Concerns C Gasteiger PhD Thesis-University of Auckland, 2022 | | 2022 |
Keith J PetrieProfessor of Health Psychology, University of AucklandVerified email at auckland.ac.nz
